Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-30
2011-12-27
Davis, Brian J (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S131000, C544S311000, C544S332000, C544S336000, C544S360000, C546S208000, C546S268100, C546S334000, C546S345000, C549S077000, C514S217040, C514S235500, C514S252100, C514S253010, C514S256000, C514S272000, C514S318000, C514S352000, C514S357000, C514S438000
Reexamination Certificate
active
08084615
ABSTRACT:
Antibacterial compounds of formula I are provided:As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
REFERENCES:
patent: 2772281 (1956-11-01), Holly et al.
patent: 5925659 (1999-07-01), Patchett et al.
patent: 6218389 (2001-04-01), Almstead et al.
patent: 6228988 (2001-05-01), Floyd et al.
patent: 6281245 (2001-08-01), Patel et al.
patent: 6358987 (2002-03-01), Beckett et al.
patent: 7358359 (2008-04-01), Andersen et al.
patent: 2001/0053555 (2001-12-01), Patel et al.
patent: 2004/0229955 (2004-11-01), Andersen et al.
patent: 2006/0154988 (2006-07-01), Andersen et al.
patent: 2007/0244197 (2007-10-01), Andersen et al.
patent: 2008/0269221 (2008-10-01), Andersen et al.
patent: 2009/0163496 (2009-06-01), Andersen et al.
patent: 2009/0247506 (2009-10-01), Andersen et al.
patent: 2011/0172174 (2011-07-01), Andersen et al.
patent: WO-9626223 (1996-08-01), None
patent: 97/05105 (1997-02-01), None
patent: WO-97/05105 (1997-02-01), None
patent: 97/42179 (1997-11-01), None
patent: WO-9742179 (1997-11-01), None
patent: 98/15525 (1998-04-01), None
patent: WO-98/15525 (1998-04-01), None
patent: WO-9818754 (1998-05-01), None
patent: WO-9822494 (1998-05-01), None
patent: 99/06340 (1999-02-01), None
patent: WO-99/06340 (1999-02-01), None
patent: WO-9939704 (1999-08-01), None
patent: WO-9957097 (1999-11-01), None
patent: WO 00/02904 (2000-01-01), None
patent: WO 00/44373 (2000-08-01), None
patent: WO 00/59874 (2000-10-01), None
patent: WO-0061134 (2000-10-01), None
patent: WO 02/30873 (2002-04-01), None
patent: WO-0250081 (2002-06-01), None
patent: WO-03/004488 (2003-01-01), None
patent: WO-2004007444 (2004-01-01), None
patent: WO 2004/062601 (2004-07-01), None
Burger's Medicinal Chemistry and Drug Discovery 5thvol. I, (1995), Manfred E. Wolff ed., John Wiley & Sons, NY, p. 975-977.
Modern Pharmaceutics 3rded., (1996), Gilbert S. Banker et al, ed., Marcel Dekker, Inc., NY, p. 596.
U.S. Appl. No. 11/837,327, filed Aug. 10, 3007, Unknown.
U.S. Appl. No. 11/981,279, filed Oct. 31, 2007, Unknown.
U.S. Appl. No. 11/289,658.
U.S. Appl. No. 11/894,208, Andersen et al.
Jackman et al., Antibacterial Agents that Target Lipid a Biosynthesis in Gram-Negative Bacteria,J. Biological Chemistry275(15):11002-11009 (2000).
Khan et al., “A Facile and Convenient Solid-Phase Procedure for Synthesizing Nucleotide Hydroxamic Acids,”Tetrahedron Letters39:8031-8034 (1998).
Kline et al., “Potent Novel In Vitro Inhibitors of thePseudomonas aeruginosaDeacetylase LpxC,”J Med. Chem. 45:3112-3129 (2002).
Mellor et al., “N-Fmoc-Aminooxy-2-Chlorotrityl Polystyrene Resin: A Facile Solid-Phase Methodology for Synthesis of Hydroxamic Acids,”Tetrahedron Letters38(18):3311-3314 (1997).
Ngu et al., “A New and Efficient Solid Phase Synthesis of Hydroxamic Acids,”J Org. Chem. 62:7088-7089 (1997).
Pirrung et al., “A Convenient Procedure for the Preparation of Amino Acid Hydroxamates from Esters,”J. Org. Chem. 60:8084-8085 (1995).
Pirrung et al., “Inhibition of the Antibacterial Target UPD-(3-0-acy1)-N-acetyglucosamine Deacetylase (LpxC): Isoxazoline Zinc Amidase Inhibitors Bearing Diverse Metal Binding Groups,” Journal of Medical Chemistry 45(19):4359-4370 (2002).
Angus et al., “Outer Membrane Permeability inPseudomonas aeruginosa: Comparison of a Wild-type with an Antibiotic-supersusceptible Mutant,” Antimocriob. Agents Chemother. 21(2):299-309 (1982).
Bergeron et al., “Effects of C-4 Stereochemistry and C-4′ Hydroxylation on the Iron Clearing Efficiency and Toxicity of Desferrithiocin Analogues,” J. Med. Chem. 42:2432-2440 (1999).
Boyce et al., “Total Synthesis of Thiangazole, a Novel Naturally Occurring HIV-1 Inhibitor from Polyangium sp,” Tetrahedron 51(26):7321-7330 (1995).
Brooks & Summers, “Modulators of Leukotriene Biosynthesis and Receptor Activation,” J. Med. Chem. 39(14):2629-2654 (1996).
Charette & Chua, “Mild Method for the Synthesis of Thiazolines from Secondary and Tertiary Amides,” J. Org. Chem. 63:908-909 (1998).
Fernandez et al., “Novel Synthesis of 2-Thiazolines,” Tetrahedron Lett. 41:3381-3384 (2000).
Galéotti et al., “Synthesis of Peptidyl Aldehydes from Thiazolidines,” Tetrahedron Left. 38(14):2459-2462 (1997).
Hyland et al., “Cloning, Expression, and Purification of UDP-3-O-Acyl-GlcNA c Deacetylase fromPseudomonas aeruginosa: A Metalloamidase of the Lipid A Biosynthesis Pathway,”J. Bacteriol. 179(6):2029-2037 (1997).
Ito et al., “Synthetic Reactions by Complex Catalysts. XXXI. A Novel and Versatile Method of IIeterocycle Synthesis,” J. Am. Chem. Soc. 95(13):4447-4448 (1973).
Ito et al., “Synthetic Reactions by Complex Catalysts XXXV. A Facile Synthetic Method of Cyclic Imino Ethers and Imino Thioethers,” Syn. Commun. 4(2):97-103 (1974).
Jeng & De Lombaert, “Endothelin Converting Enzyme Inhibitors,” Curr. Pharma. Design 3:597-614 (1997).
Jones, R.N., “Resistance Patterns Among Nosocomial Pathogens,” Chest 119(2)(Supplement):397S-404S (2001).
Matsuda et al., “Nucleosides and Nucleotides. 95. Improved Synthesis of 1-(2-Azido-2-deoxy-β-D-arabinofuranosyl)cytosine (Cytarazid) and -thymine. Inhibitory Spectrum of Cytarazid on the Growth of Various Human Tumor Cells In Vitro,”J. Med. Chem. 34:999-1002 (1991).
Nikaido, H., “Antibiotic Resistance Caused by Gram-negative Multidrug Efflux Pumps,” Clin. Infect. Dis. 27(Suppl 1):S32-S41 (1998).
Pattenden & Thom, “Naturally Occurring Linear Fused Thiazoline-thiazole Containing Metabolites: Total Synthesis of (−)-Didehydromirabazole A, a Cytotoxic Alkaloid from Blue-Green Algae,” J. Chem. Soc. Perkin Trans. 1629-1636 (1993).
Raman et al., “Titanium(IV)-mediated Tandem Deprotection-Cyclodehydration of Protected Cysteine N-Amides: Biomimetic Syntheses of Thiazoline- and Thiazole-containing Heterocycles,” Org. Lett. 2(21):3289-3292 (2000).
Righi et al., “Solution- and Solid-phase Synthesis of 4-Hydroxy-4,5-dihydroisoxazole Derivatives from Enantiomerically Pure N-Tosyl-2,3-aziridine Alcohols,” Org. Lett. 4(4):497-500 (2002).
Sahm et al., “Evaluation of Current Activities of Fluoroquinolones Against Gram-negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance,” Antimicrob. Agents Chemother. 45(1):267-274 (2001).
Shen & Thomas, “Synthesis of 1,3-Diyncs via Palladium-catalyzed Reaction of 1,1-Dibromo-1-alkenes,” Org. Lett. 2(18):2857-2860 (2000).
Shen & Wang, “The Stille Reaction of 1,1-Dibromo-1-alkenes: Preparation of Trisubstituted Alkenes and Internal Alkynes,” J. Org. Chem. 64:8873-8879 (1999).
Skotnicki et al., “Design Strategies for the Identification of MMP-13 and TACE Inhibitors,” Curr. Opin. Drug Dis. Dev. 6(5):742-759 (2003).
Wipf et al., “Thiolysis of Oxazolines: A New, Selective Method for the Direct Conversion of Peptide Oxazolines into Thiazolines,” Tetrahedron Left. 36(36):6395-6398 (1995).
Witte & Seeliger, “Cyclische Imidsäurcester aus Nitrilen and Aminoalkoholen,” Liebigs Ann. Chem. 996-1009 (1974).
Wyckoff et al., “Antibacterial and Anti-inflammatory Agents That Target Endotoxin,” Trends Microbiol. 6(4):154-159 (1998).
Zask et al., “Inhibition of Matrix Metalloproteinases: Structure Based Design,” Curr. Pharma. Design 2:624-661 (1996).
Zhang et al., “Design, Combinatorial Chemical Synthesis and In vitro Characterization of Novel Urea Based Gelatinase Inhibitors,” Bioorg. Med. Chem. Lett. 9:2823-2826 (1999).
U.S. Appl. No. 12/563,697, Andersen et al.
Chen et al., “Carbohydroxamido-Oxazolidines: Anti
Andersen Niels H.
Bowman Jason
Erwin Alice L.
Harwood Eric A.
Kline Toni
Davis Brian J
Novartis Vaccines and Diagnostics Inc.
Parent Annette S.
University of Washington
LandOfFree
Antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4260782